Cargando…

Triptolide attenuates irritable bowel syndrome via inhibiting ODC1

BACKGROUND: Irritable bowel syndrome (IBS) is a chronic disorder of the gut-brain axis with significant morbidity. Triptolide, an active compound extracted from Tripterygium wilfordii Hook F (TwHF), has been widely used as a major medicinal herb in the treatment of inflammatory disease. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ning, Zhu, Liuyan, Zhang, Xueliang, Huang, Chengbin, Xiang, Wenjun, Huang, Bingwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258977/ https://www.ncbi.nlm.nih.gov/pubmed/37308808 http://dx.doi.org/10.1186/s12876-023-02847-8

Ejemplares similares

Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
por: Zhu, Ning, et al.
Publicado: (2021)

Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice
por: Zhu, Ning, et al.
Publicado: (2022)

Exploring the Pharmacological Mechanisms of Tripterygium wilfordii Hook F against Cardiovascular Disease Using Network Pharmacology and Molecular Docking
por: Huang, Bingwu, et al.
Publicado: (2021)

Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathway
por: Zhao, Xuyong, et al.
Publicado: (2023)

Bibliometric analysis of the inflammation in diabetic cardiomyopathy
por: Zhu, Ning, et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B
por: Wang, Ling, et al.
Publicado: (2018)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes
por: Lu, Yan, et al.
Publicado: (2017)

Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis
por: Liang, Xia, et al.
Publicado: (2019)

Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development
por: Prokop, Jeremy W., et al.
Publicado: (2021)

Downregulation of MTAP promotes Tumor Growth and Metastasis by regulating ODC Activity in Breast Cancer
por: Zhang, Ying, et al.
Publicado: (2022)

Triptolide Attenuates Vascular Calcification by Upregulating Expression of miRNA-204
por: Pei, Yu-qiang, et al.
Publicado: (2021)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
por: Benno, Peter, et al.
Publicado: (2015)

ALEXITHYMIA IN IRRITABLE BOWEL SYNDROME
por: Arun, Priti
Publicado: (1998)

Probiotics and irritable bowel syndrome
por: Korpela, Riitta, et al.
Publicado: (2012)

The epidemiology of irritable bowel syndrome
por: Canavan, Caroline, et al.
Publicado: (2014)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Genetics of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2016)

Epidemiology of irritable bowel syndrome
por: Endo, Yuka, et al.
Publicado: (2015)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

Bloating in irritable bowel syndrome
por: Safaee, Azadeh, et al.
Publicado: (2011)

Pharmacotherapy for Irritable Bowel Syndrome
por: Camilleri, Michael, et al.
Publicado: (2017)

Irritable Bowel Syndrome and Synbiotics
por: Kim, Soo Young
Publicado: (2019)

Irritable bowel syndrome diagnosis
por: Tyllis, Nick
Publicado: (2019)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Postinfection Irritable Bowel Syndrome
por: Ghoshal, Uday C
Publicado: (2022)

The neurobiology of irritable bowel syndrome
por: Mayer, Emeran A., et al.
Publicado: (2023)

Irritable Bowel Syndrome and Antidepressants
por: Curtiss, Frederic R.
Publicado: (2008)

Irritable Bowel Syndrome and Resilience
por: Fadgyas Stanculete, Mihaela, et al.
Publicado: (2023)

Economic burden of irritable bowel syndrome in China
por: Zhang, Fang, et al.
Publicado: (2016)

Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment
por: Huang, Kai-Yue, et al.
Publicado: (2023)

The role of inflammation in irritable bowel syndrome (IBS)
por: Ng, Qin Xiang, et al.
Publicado: (2018)

Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder
por: Liu, Chia-Jen, et al.
Publicado: (2015)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Aggregation of ODC(I) and POL Defects in Bismuth Doped Silica Fiber
por: Li, Xiaofei, et al.
Publicado: (2023)

Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
por: Ida, Motoko, et al.
Publicado: (2017)

Noninvasive Diagnosis of Irritable Bowel Syndrome via Bowel Sound Features: Proof of Concept
por: Du, Xuhao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cc4v4tkfvlfeede3pv438m1jke